StockNews.AI
HRMY
StockNews.AI
182 days

Harmony Biosciences to Report Fourth Quarter and Full Year 2024 Financial Results on February 25, 2025

1. Harmony Biosciences will report Q4 and full year 2024 results on February 25, 2025. 2. A conference call will be held to discuss these results, potentially influencing HRMY stock.

Earnings
-8.49%Current Return
VS
+0.5%S&P 500
$38.9802/18 08:46 AM EDTEvent Start
$35.6702/19 03:34 PM EDTLatest Updated
2m saved
Insight
Article

FAQ

Why Neutral?

The scheduled reporting is standard practice and unlikely to significantly affect stock prices.

How important is it?

Earnings reports are important, but past performance and market conditions may have a greater effect.

Why Short Term?

The impact is limited to the immediate event of the earnings report.

Related Companies

HRMY
PLYMOUTH MEETING, Pa.--(BUSINESS WIRE)--Harmony Biosciences Holdings, Inc. (Nasdaq: HRMY) today announced that it will report fourth quarter and full year 2024 financial results on Tuesday, February 25, 2025, before the open of the U.S. financial markets. Harmony will host a conference call and webcast on February 25, 2025, at 8:30 a.m. ET to discuss the results. To participate in the call, please dial 800-445-7795 (domestic) or 785-424-1699 (international), and reference passcode HRMYQ424. It.

Related News